Grössmann, N. and Wild, C. (2020): Update PET/PET-CT evidence for need based planning in the area of oncology. AIHTA Policy Brief 003.

Winkler, R. and Wild, C. (2020): Implantation of a wireless pulmonary artery pressure sensor in patients with advanced heart failure. Decision Support Document 119.

Wild, C. and Wohlhöfner, K. and Sehic, O. and Grössmann, N. (2020): CAR-T Cell Therapies, ATMP and Gene Therapies in Development, Horizon Scanning: ATMPs and Gene Therapies. AIHTA Policy Brief 006b.

Jeindl, R. and Wild, C. (2020): Framework for reimbursement decisions of digital health technologies (mHealth) and its (retrospective) application on selected examples. HTA-Projektbericht 134.

Wild, C. and Sehic, O. (2020): Proton and carbon ion therapy - an update on indications. AIHTA Policy Brief 004.

Grössmann, N. and Wolf, S. and Wild, C. (2021): Endoscopic plication therapy in patients with gastroesophageal reflux disease (GERD). Decision Support Document 127.

Sehic, O. and Wild, C. (2021): Non-interventional studies (NIS) in Austria, 2nd update of systematic analyses 2016 & 2017. AIHTA Policy Brief 010.

Erdos, J. and Sehic, O. and Wild, C. (2021): ≥ 12 Month Follow-Up of Patients with Spinal Muscular Atrophy (SMA) treated with Spinraza®, Zolgensma® or Combination Therapies. AIHTA Policy Brief 001/ 1. Update.

Sehic, O. and Wild, C. (2022): CAR-T Cell-Therapies in Development, Update 2022. AIHTA Policy Brief 006a/ 1. Update.

Sehic, O. and Wild, C. (2022): ATMPs and Gene Therapies in Development. Horizon Scanning – Update 2022. AIHTA Policy Brief 006b/ 1. Update.

Hofer, V. and Wild, C. (2022): Upper airway stimulation for moderate-to-severe sleep apnoea. Update 2022. Decision Support Document 100/ Update 2022.

Gassner, L. and Wild, C. and Hofer, V. (2022): Chemosaturation with percutaneous hepatic perfusion for patients with liver cancer. Decision Support Document 133.

Panhuber, A. and Titieni-Schuhmann, A. and Goetz, G. and Wild, C. (2022): CAR-T cell therapy: Contrasting the evidence from pivotal trials with the real world evidence (RWE). HTA-Projektbericht 146.

Giess, D. and Erdos, J. and Wild, C. (2023): SMA-Therapies: Mid- to longer-term follow-up of spinal muscular atrophy (SMA) patients treated for ≥24 months with nusinersen or onasemnogene abeparvovec as monotherapies or in combination, and patients treated for ≥12 months with risdiplam as monotherapy or in combination. AIHTA Policy Brief 001/ 2. Update.

Ettinger, S. and Wild, C. (2023): CORE-MD Roadmap for Education & Training: Perceived training needs of regulators, notified bodies and clinicians for successful implementation of the EU MDR. AIHTA Policy Brief 000.

Wild, C. and Fabian, D. (2024): The Role of Public Contributions to the Development of Health Innovations. HTA-Projektbericht 158.

Wild, C. and Erdos, J. and Jeindl, R. (2024): Biomarkers in Parkinson's Disease. Rapid Review Nr.: 010.

Huic, M. and Erdos, J. and Wild, C. (2024): Point of Care Tests (POCT): D-Dimer and Troponin. HTA-Projektbericht 124/ 1. Update.

Wild, C. and Langer, T. (2006): Horizon Scanning System (HSS). An Overview. HTA-Projektbericht 02.

Wild, C. (2000): [Erythropoietin in patients with fatigue syndrome]. forum dr. Med. (13): pp. 4-5.

Wild, C. (2003): [Erythropoietin: The impact of HTA]. ÖKZ: Österreichische Krankenhauszeitung 44 (12): pp. 9-10.

Wild, C. and Jonas, S. and Schamberger, C. (2002): [Predictive genetic diagnostics for hereditary cancer]. Mitteilungen der Sanitätsverwaltung 01: pp. 6-8.

Wild, C. and Perleth, M. (2001): Possibilities for partial integration of Health Technology Assessment (HTA) and Technology Assessment (TA). TA-Datenbank-Nachrichten 10 (01): pp. 55-58.

Wild, C. and Perleth, M. (2001): [Health technology assessment: An introduction]. TA-Datenbank-Nachrichten 10 (01): pp. 6-12.

Wild, C. (2000): [Health technology assessment: A steering tool]. Mitteilung der Sanitätsverwaltung (01): pp. 6-8.

Wild, C. (2004): [The myth of cancer prevention: Heresy or guidance to maturity]. ÖKZ: Österreichische Krankenhauszeitung 45 (4): pp. 10-11.

Wild, C. and Jonas, S. (2003): [To what extent can the publicly sponsored health system afford predictive genetic diagnostics? - First approaches to pinpoint and limit responsibilities, exemplified by hereditary carcinomas]. Das Gesundheitswesen 65 (06): pp. 351-358.

Wild, C. (2002): Erythropoietin in tumor anemia - for whom is effective?. International Journal of Cancer 13 (Supplement): p. 70.

Wild, C. (2005): [Medical technology assessment]. Austrian conference of hospital technicians. Pörtschach, 28.09.2005.

Wild, C. and Jonas, S. and Frank, W. and Schmetterer, L. and Sycha, T. (2002): [Immunoglobulins in transplant medicine. Prevention and therapy of cytomegalovirus infections: An Assessment]. Transplantationsmedizin (02): pp. 65-73.

Wild, C. (2001): [Assessing medical interventions]. ManagMed (3).

Wild, C. and Jonas, S. (2002): [Predictive genetic testing for breast and colon cancer]. Newsletter der Österreichischen Gesellschaft für Public Health (3): p. 1.

Wild, C. (2003): [Cardiac resynchronisation therapy (CRT) for heart failure]. HTA-Newsletter 23: pp. 3-4.

Wild, C. (2005): [Depression: Screening]. HTA-Newsletter 36: pp. 2-3.

Wild, C. (2005): [Provocation-neutralisation therapy for food allergy]. HTA-Newsletter 34: p. 4.

Wild, C. and Schimetta, W. (2005): [Application studies]. ITA-Newsletter December 2005: pp. 5-6.

Wild, C. (2005): [Advance directives: Comment of the Viennese Bioethics Commission]. ITA-Newsletter September 2005: pp. 12-13.

Wild, C. and Blagojevic, S. (2012): Annual Report 2011. German Version.

Jonas, S. and Schamberger, C. and Wild, C. (2002): [Predictive genetic diagnosis for breast and colon carcinoma: Diagnosis, treatment, public health aspects]. ITA-Projektbericht 21.

Wild, C. (2006): [Austrian HTA institute founded. The Ludwig Boltzmann Institute of HTA starts working. Editorial]. HTA-Newsletter 47: p. 1.

Wild, C. (2003): [Treatment of chronic pain: Multidisciplinary programmes]. HTA-Newsletter 18: pp. 3-4.

Wild, C. (2004): [Liposuction in cosmetic surgery]. HTA-Newsletter 28: p. 2.

Wild, C. (2002): [Pharmacogenetics]. HTA-Newsletter 13: p. 4.

Wild, C. (2003): [Electric stimulation for faecal incontinence]. HTA-Newsletter 23: pp. 2-3.

Wild, C. (2003): [High-dose lymphoablative therapy (HDLT) for severe autoimmune diseases]. HTA-Newsletter 21: pp. 2-3.

Wild, C. (2003): [HTA interactive link collection. Editorial]. HTA-Newsletter 22: p. 1.

Wild, C. (2004): [Radiofrequency ablation: Therapy of liver tumours] . HTA-Newsletter 26: p. 4.

Wild, C. (2004): [Low-intensity pulsed ultrasound for bone healing in pseudarthrosis]. HTA-Newsletter 28: pp. 2-3.

Wild, C. (2003): [Virtual colonoscopy]. HTA-Newsletter 18: pp. 2-3.

Wild, C. (2005): [Impact of HTA]. HTA-Newsletter 33: p. 4.

Felder-Puig, R. and Wild, C. (2004): Current research and funding in the EU25 countries in the area of asthma in children. Fast-track study initiated by the Joint Research Centre of the European Commission. ITA-Projektbericht 27.

Wild, C. and Jonas, S. (2000): [Symposium "Evidence-based Medicine"]. ITA-Newsletter December 2000: pp. 8-9.

Wild, C. (2004): [Drug eluting stents: An economic analysis]. HTA-Newsletter 31: pp. 3-4.

Wild, C. (2001): [Approval of innovative drugs]. ORF ON Science.

Kis, A. and Wild, C. and Bodamer, O. (2008): Enzyme Replacement Therapy for Lysosomal Storage Diseases. Decision Support Document 19.

Wild, C. (1997): [Forecasting in medicine: expert opinions]. Das Gesundheitswesen 59: pp. 467-472.

Wild, C. (1994): [Safety alarm systems and housing adaptation with technical aids]. Berliner Pflege Blatt 1994.

Wild, C. (2004): [Genetic testing for predisposition]. ITA-Newsletter December 2004: p. 8.

Wild, C. (2000): Health technology assessment. In: Fischer, R. and Tragl, H. Ökonomie und Gesundheit. Lösbare Herausforderungen oder dauernder Widerspruch?: Wien: Österreichischer Ärzte Verlag, pp. 249-264.

Peissl, W. and Tschakalov, P. and Wild, C. (1991): [Effects of Medcard/patient card in Austria]. ITA-Projektberichte.

Wild, C. (2005): [Health technology assessment: An introduction]. Newsletter des NÖ-Patientenanwalts April 2005.

Wild, C. and Peissl, W. (1992): Patient cards: An assessment of a new information technology in health care. Project Appraisal 7 (2): pp. 67-78.

Wild, C. and Kirschner, A. (1993): [Technology and ageing I: Safety alarm systems and counseling for housing adaption]. ITA-Projektberichte.

Wild, C. and Torgersen, H. (2000): Forecasting in medicine: The results of three European Delphi Studies. European Journal of Public Health 10 (02): pp. 114-119.

Wild, C. and Goldgruber, R. (2004): [Assessment of non-ionic contrast media]. ITA-Newsletter March 2004: p. 4.

Adlbrecht, C. and Wild, C. (2007): [Photoselective vaporisation of the prostate in men with benign prostatic hyperplasia. HTA in hospitals]. Decision Support Document 01.

Wild, C. (1990): [The social implications of the increasing spread of technology in health care]. Journal für Sozialforschung 30 (03): pp. 294-317.

Wild, C. and Jonas, S. (2001): [Health policy decisions between rationing and rationalisation as demonstrated by the example of erythropoietin in tumour anaemia]. Das Gesundheitswesen 63 (2): pp. 221-225.

Wild, C. (2005): [Vertebroplasty and kyphoplasty]. ÖKZ: Österreichische Krankenhauszeitung 46 (11): p. 18.

Wild, C. (2001): [Stem cell research, quo vadis?]. ORF ON Science.

Wild, C. (2004): [HTAi annual meeting in Krakow]. ZaeFQ: Zeitschrift für ärztliche Fortbildung und Qualitätssicherung 98: p. 556.

Wild, C. (2001): [Immunoglobulins: Effectiveness and costs]. ORF ON Science.

Wild, C. (2002): [Is critical journalism contradictory to the reporting of innovations?]. ZaeFQ: Zeitschrift für ärztliche Fortbildung und Qualitätssicherung (96): p. 336.

Wild, C. and Khene, M. and Wanke, S. (2000): ESWT: Extracorporeal shock wave therapy - Assessment of an emerging health technology. International Journal of Technology Assessment in Health Care 16 (01): pp. 199-209.

Wild, C. (2005): [Health technology assessment, economics and health]. Austrian Public Health association conference. Linz, 07.-08.06.2005.

Banta, H.D. and Oortwijn, W.J. and Wild, C. (1998): Health technology assessment in Europe: The challenge of coordination. TNO Research Report PG/VGZ/98.015.

Mikl, M. and Wild, C. and Torgersen, H. (1995): [Genetic analysis: Practice of diagnosis and counseling in Austria]. ITA-Projektberichte.

Wild, C. and Mikl, M. (1996): [Medical genetics in Austria: Opportunities and risks]. Soziale Technik (3): pp. 6-8.

Braun, E. and Hawle, M. and Wild, C. (1990): [Social implications of the increasing spread of technology in medicine]. ITA-Projektberichte.

Jonas, S. and Wild, C. and Schamberger, C. (2002): Predictive genetic testing for mammary and colorectal cancer. Wiener Klinische Wochenschrift 114 Suppl. (17-18): p. 24.

Hörl, J. and Pärtan, G. and Wild, C. (1991): [Technology and Ageing: The maintenance of independency and self-determination of aged people]. ITA-Projektberichte.

Wild, C. and Narath, M. (2002): [Evidence-based ICU bed planning]. Mitteilungen der Sanitätsverwaltung 01: pp. 9-12.

Wild, C. and Leitner, S. (1997): [Technology and Ageing II: European initiatives, neighbourhood-initiatives, Internet-services]. ITA-Projektberichte.

Wild, C. (2003): [Erythropoietin: The impact of HTA] . Mitteilungen der Sanitätsverwaltung 104 (9): p. 23.

Wild, C. and Kirschner, A. (1994): [Safety alarm systems and housing adaptation: Technical aids for the elderly]. Häusliche Pflege (06): pp. 381-389.

Wild, C. (2001): [Evidence-based medicine: Continuing education for diabetologists].

Wild, C. (2007): [Health technology assessment]. European Forum Alpbach. Vienna, 28.03.2007.

Gebetshuber, I. and Ratzer, B. and Wild, C. (1997): [Biomedical research projects and socio-scientific issues]. TA-Datenbank-Nachrichten 06 (02): pp. 36-41.

Wild, C. (2002): Situation of HTA in the German speaking countries - Health technology in Austria. In: The Challenge of Collaboration. Proceedings of the 18th Annual Meeting of the International Society of Technology Assessment in Health Care: München-Jena: Urban & Fischer.

Wild, C. and Jonas, S. (2000): [Erythropoietin (EPO) in tumour anaemia]. Newsletter der Österreichischen Gesellschaft für Public Health (4): pp. 1-2.

Wild, C. (1994): Experiences with counseling for housing adaption in Austria and Germany. Safety Alarm Systems, Technical Aids and Smart Homes (06): pp. 153-172.

Wild, C. (2000): [The C-reactive protein test in the diagnosis of infections]. ITA-Newsletter September 2000: p. 3.

Wild, C. and Jonas, S. and Rafetseder, O. (2004): [Colon cancer screening]. Mitteilungen der Sanitätsverwaltung 11: pp. 14-15.

Wild, C. (1997): [Medical technology assessment (MTA)]. ÖKZ: Österreichische Krankenhauszeitung 38 (06).

Busse, R. and Orvain, J. and Velasco-Garrido, M. and Perleth, M. and Drummond, M. and Wild, C. (2002): Best practice in undertaking and reporting health technology assessment. International Journal of Technology Assessment in Health Care 18 (02): pp. 361-422.

Falkner, E. and Eder, C. and Wild, C. (2007): Evaluation of regenerative medicine/tissue engineering approaches by health technolgy assessment. Regenerative Medicine 2007. (In Press)

Wild, C. (1994): [Housing adaptation in Austria and Germany]. Zeitschrift für Gerontologie 27 (06): pp. 381-389.

Wild, C. (1997): [Patient organisations]. GID: Gen-ethischer Informationsdienst (6).

Gebetshuber, I. and Ratzer, B. and Wild, C. (1997): [Biomedical research projects and socio-scientific issues] . Soziale Technik (1): pp. 12-15.

Wild, C. and Mikl, M. (1996): [Medical genetics in Austria]. Journal für Sozialforschung 36 (01): pp. 87-108.

Wild, C. and Gibis, B. (2002): Evaluations of health interventions in social insurance-based countries: Germany, the Netherlands, and Austria. Health Policy 63 (02): pp. 187-196.

Wild, C. and Peissl, W. (1996): [Patient cards: An assessment of a new information technology in health care]. In: Tichy, G. Technikfolgenabschätzung in Österreich – Entscheidungshilfe in einer komplexen Welt, Beispiele aus der Praxis: Wien: Verlag der Österreichischen Akademie der Wissenschaften.

Wild, C. (1993): [Gerontechnology: Technologies for the elderly]. Soziale Technik (2): pp. 15-16.

Wild, C. (1998): [Neighbourly help]. Häusliche Pflege (12): pp. 33-41.

Wild, C. (1998): [What do Austrian experts think about health care?]. ManagMed (2): pp. 33-35.

Hinterreiter, G. and Wild, C. (2009): Annual report 2008. English version.

Wild, C. and Peissl, W. and Tellioglu, H. (1998): An Assessment of PACS: The Case Study of the SMZO Project. International Journal of Technology Assessment in Health Care 14 (03): pp. 573-582.

Wild, C. (2001): [Building a safer health system]. ORF ON Science.

Wild, C. (2000): [HTA and decision making]. TA-Datenbank-Nachrichten 09 (04): pp. 152-153.

Wild, C. (1999): [Organised neighbourly help in Styria]. In: Schöpfer, G. Seniorenreport Steiermark. Altwerden in der Steiermark: Lust oder Last: Graz: Universität Graz Inst. f. Wirtsch.- u. Sozialgesch., pp. 55-58. ISBN 978-3901674068.

Wild, C. (2000): Country report: Health technology assessment in Austria. International Journal of Technology Assessment in Health Care 16 (02): pp. 303-324.

Wild, C. (1996): [Gerontology and technologies]. In: Tichy, G. Technikfolgenabschätzung in Österreich: Wien: Verlag der Österreichischen Akademie der Wissenschaften.

Wild, C. (1996): [Medical technology assessment: The social implications of the increasing spread of technology in health care]. In: Tichy, G. Technikfolgenabschätzung in Österreich: Wien: Verlag der Österreichischen Akademie der Wissenschaften.

Wild, C. and Wanke, S. (1999): [Extracorporeal shock wave therapy: An assessment]. ÖKZ: Österreichische Krankenhauszeitung 40 (03): pp. 20-21.

Jonas, S. and Jessner, W. and Rafetseder, O. and Wild, C. (2005): [Chronic hepatitis C in Austria]. Mitteilungen der Sanitätsverwaltung 01: pp. 5-7.

Wild, C. and Jonas, S. and Frank, W. and Schmetterer, L. and Sycha, T. (2001): [Immunoglobulins in transplant medicine. Prevention and therapy of cytomegalovirus infections: An Assessment]. European Surgery: Acta Chirurgica Austriaca 33 (Supplement 178).

Wild, C. (2005): [Cerebral microdialysis: Neuromonitoring]. HTA-Newsletter 42: p. 4.

Wild, C. (2005): [Stroke rehabilitation] . HTA-Newsletter 41: p. 2.

Hinterreiter, G. and Wild, C. and Blagojevic, S. (2010): Annual Report 2009. German version.

Wild, C. (2001): [Swedish EU presidency puts emphasis on health policy]. ORF ON Science.

Blagojevic, S. and Winkler, R. and Wild, C. and Hinterreiter, G. (2010): Annual Report 2009. English version.

Wild, C. and Gregor-Patera, N. (2015): HTA-Strategy for Lithuania. Decision Support Document 90a.

Wild, C. (2001): [Assessing medical interventions: Erythropoietin in tumour anaemia]. TA-Datenbank-Nachrichten (01, Sonderheft): pp. 51-55.

Wild, C. (1999): HTA in Austria: PACS and ESWT. Medical and Biological Engineering & Computing (Supplement 4).

Wild, C. and Narath, M. (2003): [Evidence-based intensive care planning. A systematic review of recent ICU-plans and planning approaches]. Intensivmedizin und Notfallmedizin 40 (05): pp. 412-419.

Hinterreiter, G. and Wild, C. (2009): [Annual report 2008. German version] .

Wild, C. (2003): [HTA and its impact in Austria]. In: Meggeneder, O. Unter-, Über- und Fehlversorgung. Vermeidung und Management von Fehlern im Gesundheitswesen: Frankfurt/Main: Mabuse-Verlag, pp. 131-146. ISBN 3-935964-31-5.

Wild, C. (2015): Biodegradable stents for the treatment of refractory or recurrent benign oesophageal stenoses. Decision Support Document 89.

Wild, C. (2007): [FDA: Safety warning on erythropoietin]. HTA-Newsletter 58: p. 4.

Schiller-Frühwirth, I. and Johansson, T. and Göbl, M. and Reiselhuber, S. and Wild, C. (2009): Folic acid fortification of flour in Austria - Risks and benefits. HTA-Projektbericht 020.

Wild, C. (2005): [Avastin®/Bevacizumab for metastatic colorectal cancer]. ÖKZ: Österreichische Krankenhauszeitung 46 (10): p. 51.

Wild, C. (2005): [Health technology assessment]. ÖKZ: Österreichische Krankenhauszeitung 46 (10): p. 50.

Wild, C. (2005): [Priority setting for the assessment of medical interventions]. Mitteilungen der Sanitätsverwaltung 5: pp. 9-11.

Wild, C. (2001): Screening in Austria - the cases of mammography, PSA-testing and routine use of ultrasonography in pregnancy. International Journal of Technology Assessment in Health Care 17 (03): pp. 305-315.

Wild, C. (2006): [Proton therapy]. ÖKZ: Österreichische Krankenhauszeitung 47 (03): p. 19.

Wild, C. (2013): Percutaneous transluminal septal myocardial ablation (PTSMA) in hypertrophic obstructive cardiomyopathy (HOCM) . Decision Support Document 71.

Zechmeister, I. and Wild, C. and Langer, T. and Koller, D. (2007): [Neonatal care of low-risk newborns by paediatricians. An approach to evidence-based health care planning]. Monatsschrift Kinderheilkunde July 2007. (Submitted)

Wild, C. (2005): [HTA: Assessing health technologies]. Dialogue on intensive care medicine. Baden/Vienna, 29.10.2005.

Kirisits, A. and Wild, C. (2012): Efficacy of Hyperthermia Treatment in combination with radio- or chemotherapy in Breast-, Bladder-, Cervix Carcinoma and Soft Tissue Sarcoma patients. Update 2012. Decision Support Document 36 / Update 2012.

Wild, C. and Zechmeister, I. (2007): [Theories of distributional justice in health care and the role of HTA]. Kurswechsel 2: pp. 87-88.

Gartlehner, G. and Wild, C. and Mad, P. (2008): [Systematic reviews and meta-analyses]. WMW: Wiener Medizinische Wochenschrift 158 (3-4): pp. 127-133.

Wild, C. (2008): Polymorphism-screening: genetic testing for predisposition - guidance for technology assessment. Poiesis & Praxis: International Journal of Ethics of Science and Technology Assessment 05 (01): pp. 1-14.

Wild, C. and Mathis, S. and Guba, B. and Gartlehner, G. (2008): [Rheopheresis in patients with age-related macular degeneration, sudden hearing loss or tinnitus, diabetes. Systematic review]. Decision Support Document 12.

Wild, C. (2005): [Nanotechnology in medical research]. HTA-Newsletter 38: pp. 3-4.

Wild, C. (2013): Repair of cartilage defects via matrix-associated autologous chondrocyte immigration. Decision Support Document 66.

Wild, C. (2005): [Allocation of resources: Methods of a rational approach]. IIR Health Conference. Vienna, 21. Oktober 2005.

Wild, C. and Gregor-Patera, N. and Stricka, M. and Karnickas, L. (2015): Background Analysis for National HTA Strategy for Lithuania: Focus on Medical Devices. Decision Support Document 90.

Wild, C. (2004): [Sentinel node biopsy (SNB) in breast cancer]. HTA-Newsletter 24: pp. 2-3.

Wild, C. (2005): [Foundation of an Austrian HTA institute. Editorial]. HTA-Newsletter 33: pp. 1-2.

Wild, C. and Gartlehner, G. (2007): [Health technology assessment]. WMW: Wiener Medizinische Wochenschrift 2007. (Submitted)

Wild, C. (2006): [Cervical smear tests]. HTA-Newsletter 45: pp. 3-4.

Jonas, S. and Rafetseder, O. and Wild, C. (2005): [Colorectal cancer screening in Austria: Integrating coloscopy into the preventive medical check up]. Journal für Gastroenterologische und hepatologische Erkrankungen 03: pp. 11-15.

Wild, C. (2007): [Resource allocation in paediatrics]. 1st Annual Meeting of Childhood Medicine. Salzburg, 19.-20.10.2007.

Wild, C. (2006): [Generics vs. brand name drugs after patent expiration] . ÖKZ: Österreichische Krankenhauszeitung 47 (10): p. 16.

Wild, C. (2006): [EUnetHTA: A network of HTA agencies in Europe]. ÖKZ: Österreichische Krankenhauszeitung 47 (11): p. 17.

Wild, C. (2006): [Foundation of a HTA institute in Austria]. ÖKZ: Österreichische Krankenhauszeitung 47 (6): p. 16.

Wild, C. (2005): [Quantitative polymerase chain reaction (Q-PCR) in fetal diagnosis of chromosomal abnormalities] . HTA-Newsletter 37: p. 4.

Kisser, A. and Mayer, J. and Wild, C. (2014): Opportunities and strategies to drive appropriate use of MRI in Austria. HTA-Projektbericht 80.

Wild, C. (2006): [Neuromodulation for Parkinson´s disease and chronic pain]. ÖKZ: Österreichische Krankenhauszeitung 47 (02): p. 16.

Wild, C. (2006): [Financing health care: The impact of health technology assessment]. In: Amler, M. and Bencic, W. Ökonomie und Gesundheit. Lösbare Herausforderungen oder dauernder Widerspruch?: Gesundheitswissenschaften (30). Linz: OÖ Gebietskrankenkasse, pp. 49-53. ISBN 3-900581-47-9.

Wild, C. (2007): [Health technology assessment in Austria]. In: Perleth, M. and Busse, R. and Gerhardus, A. and Gibis, B. Health Technology Assessment. Konzepte, Methoden, Praxis für Wissenschaft und Entscheidungsfindung: Berliner Schriftenreihe Gesundheitswissenschaften. Berlin: MWV Medizinisch Wissenschaftliche Verlagsgesellschaft OHG, pp. 37-40. ISBN 978-3-939069-22-5.

Wild, C. (2007): [Horizon scanning]. ÖKZ: Österreichische Krankenhauszeitung 48 (04): p. 16.

Felder-Puig, R. and Turk, E. and Guba, B. and Wild, C. (2006): [Therapeutic conversation: The effectiveness of intensified physician-patient communication]. HTA-Projektbericht 01.

Wild, C. (2007): [Drug eluting stents. Status quo]. ÖKZ: Österreichische Krankenhauszeitung 48 (03).

Wild, C. and Adlbrecht, C. (2007): [Avastin for age-related macular degeneration]. Rapid Assessment LBI-HTA 02.

Wild, C. (2005): HTA in hospitals: A network of Austrian hospitals. HTAi Annual Conference. Rome, 20.-22.05.2005.

Wild, C. (2007): [Health technology assessment in Austria]. UMIT-PH course. Hall/Tyrol, 17.04.2007.

Zechmeister, I. and Freiesleben de Blasio, B. and Radlberger, P. and Wild, C. and Kvas, E. and Garnett, G. and Neilson, A. R. (2007): [Economic evaluation of HPV vaccination in Austria]. HTA-Projektbericht 09.

Wild, C. (2005): [Minimally invasive treatment for herniated discs]. HTA-Newsletter 39: p. 2.

Wild, C. (2005): . HTA-Newsletter 40: p. 4.

Wild, C. (2004): [Rituximab (MabThera®) as treatment for non-Hodgkin's lymphoma]. HTA-Newsletter 32: p. 3.

Wild, C. (2005): [Autologous blood donation]. HTA-Newsletter 38: p. 2.

Wild, C. (2005): Ethics of Resource Allocation: Instruments for rational decision-making in support of a sustainable health care. Poiesis & Praxis: International Journal of Ethics of Science and Technology Assessment 03 (04): pp. 296-309.

Krüger, L.J. and Wild, C. (2013): Evidence requirements for the authorization and reimbursement of high-risk medical devices in the USA, Europe, Australia and Canada: An analysis of seven high-risk medical devices. HTA-Projektbericht 73.

Warmuth, M. and Mad, P. and Wild, C. (2009): Haemocomplettan® P alone or in combination with Fibrogammin® P in acquired hypofibrinogenemia. HTA-Projektbericht 039.

Wild, C. (2005): [Sleep disorders: Referral of patients to sleep laboratories]. HTA-Newsletter 39: pp. 3-4.

Wild, C. (2002): [Trastuzumab for breast cancer]. HTA-Newsletter 12: p. 2.

Wild, C. (2006): [Antiviral treatment for chronic hepatitis C]. HTA-Newsletter 45: p. 4.

Wild, C. (2006): [Non-ionic contrast media]. ÖKZ: Österreichische Krankenhauszeitung 47 (7/8): p. 16.

Wild, C. (2005): [Molar root treatment]. HTA-Newsletter 39: pp. 2-3.

Wild, C. (2005): [Herceptin®/Trastuzumab for metastatic breast cancer]. HTA-Newsletter 40: p. 3.

Wild, C. (2006): [Foundation of the Ludwig Boltzmann Institute Health Technology Assessment]. Technikfolgen-Abschätzung – Theorie & Praxis 03 (15): pp. 77-79.

Joppi, R. and Wild, C. (2012): Vemurafenib for patients with BRAF V600E mutation positive advanced/metastatic melanoma. DSD: Horizon Scanning in Oncology 23.

Wild, C. (2005): [Hip ultrasound in newborns: An update]. HTA-Newsletter 39: p. 4.

Wild, C. (2007): [Funding programme of the Vienna Science and Technology Fund (WWTF)]. ÖKZ: Österreichische Krankenhauszeitung 48 (01): p. 16.

Wild, C. and Blagojevic, S. (2013): Annual Report 2012.

Wild, C. (2003): [Troponin testing in acute coronary syndromes]. HTA-Newsletter 18: p. 4.

Wild, C. and Piribauer, F. and Stergner, A. (2009): New influenza (swine flu) – data & facts for decision support. Decision Support Document 35.

Wild, C. (2001): [Chronic fatigue syndrome]. HTA-Newsletter 01: p. 2.

Wild, C. (2001): [Limitations of evidence based medicine. Editorial]. HTA-Newsletter 01: p. 1.

Wild, C. and Antes, G. (2004): [Registration of all clinical trials]. ITA-Newsletter December 2004: p. 13.

Wild, C. (2002): [Clopidogrel (Plavix): Secondary prevention of coronary heart disease]. HTA-Newsletter 04: p. 2.

Wild, C. (2001): [HTA link list]. HTA-Newsletter 03: p. 4.

Wild, C. (2002): [Proton radiation]. HTA-Newsletter 11: p. 2.

Wild, C. (2002): [Acupuncture]. HTA-Newsletter 04: pp. 2-4.

Wild, C. (2003): [Endovascular surgery for abdominal aortic aneurysm/AAA]. HTA-Newsletter 15: p. 4.

Wild, C. (2002): [Drug therapy for adiposity]. HTA-Newsletter 08: pp. 3-4.

Wild, C. (2002): [Glycoprotein IIb/IIIa inhibitors in the treatment of acute coronary syndromes]. HTA-Newsletter 13: pp. 2-3.

Wild, C. (2003): [Clinical economics. Editorial]. HTA-Newsletter 19: pp. 1-2.

Wild, C. (2002): [Treatment of varicose veins]. HTA-Newsletter 12: pp. 3-4.

Wild, C. (2003): [Implantable cardioverter defibrillator]. HTA-Newsletter 14: p. 4.

Wild, C. (2002): [Coated stents]. HTA-Newsletter 13: pp. 3-4.

Wild, C. (2012): Avastin for Age-related Macular-Degeneration. Evidence synthesis after CATT, IVAN, MANTA. Rapid Assessment 005.

Wild, C. (2003): [Pegylated interferon alpha for chronic hepatitis C]. HTA-Newsletter 17: pp. 3-4.

Wild, C. (2003): [Vertebroplasty and kyphoplasty]. HTA-Newsletter 17: pp. 2-3.

Wild, C. (2002): [Visual electrodiagnosis]. HTA-Newsletter 12: p. 4.

Dellinger, J. and Wild, C. (2012): Universal HIV-Testing. International Recommendations and actual risk of HIV-Infections for Healthcare-Workers. Decision Support Document 61.

Wild, C. (2007): [Growth hormones: Possible late effects]. HTA-Newsletter 54: pp. 3-4.

Wild, C. (2003): [Decision making: A systematic checklist]. ITA-Newsletter September 2003: p. 11.

Wild, C. and Jonas, S. (2000): [Erythropoietin in tumour anaemia. An assessment]. ITA-Projektbericht 15.

Wild, C. and Frank, W. and Huber, K. and Konta, B. (2003): [GP IIb/IIIA inhibitors in the treatment of patients with coronary heart disease]. Köln: DIMDI. ISBN 3-89906-703-7.

Wild, C. and Zechmeister, I. (2007): [Allocation of resources and equity. Editorial]. HTA-Newsletter 59: p. 1.

Wild, C. (2005): [Contours of a basic health care benefit package. Editorial]. HTA-Newsletter 34: p. 1.

Wild, C. and Langley, T. and Guba, B. and Gartlehner, G. (2008): [Percutaneous aortic valve replacement. Systematic review]. Decision Support Document 18.

Jonas, S. and Wild, C. and Schmetterer, L. and Sycha, T. and Frank, W. (2001): [Immunoglobulins in transplant medicine: Prevention and therapy of cytomegalovirus infections. Systematic review and meta-analysis]. ITA-Projektbericht 19.

Hinterreiter, G. and Wild, C. (2011): Annual Report 2010. German Version.

Wild, C. (2006): [Carotid stenting for carotid artery stenosis]. HTA-Newsletter 46: p. 4.

Wild, C. (2001): [Stem cells: Quo vadis?]. ITA-Newsletter September 2001: pp. 8-9.

Wild, C. (2005): [Coronary heart disease. Risk models]. HTA-Newsletter 36: p. 3.

Wild, C. (2005): [Screening for abdominal aortic aneurysm (AAA)]. HTA-Newsletter 36: p. 2.

Wild, C. and Jonas, S. and Frank, W. and Traunmüller, F. (2001): [Invasive aspergillosis: State of the art in diagnosis, treatment and conditions. An assessment]. ITA-Projektbericht 18.

Wild, C. and Adlbrecht, C. (2007): [Laser vaporisation of benign prostatic hyperplasia]. HTA-Newsletter 56: p. 2.

Wild, C. and Geiger-Gritsch, S. and Mittermayr, T. (2009): [Percutaneous aortic valve replacement. Systematic review]. Decision Support Document 18/Update2009.

Wild, C. and Puig, S. (2003): [Non-ionic contrast media: clinical relevance of different CM-products]. ITA-Projektbericht 24.

Wild, C. (1999): [National insurance in Germany and Swiss: Removal of ineffective medical services from the individual medical services catalogue]. ITA-Newsletter October 1999: pp. 20-21.

Wild, C. (2006): [Austrian HTA institute founded]. ITA-Newsletter June 2006: pp. 9-10.

Wild, C. (2004): [Communication and error management culture. Editorial]. HTA-Newsletter 32: p. 1.

Wild, C. (2004): [The excimer laser: Treatment of short-sightedness]. HTA-Newsletter 26: p. 2.

Pammer, C. and Abuzahra, M. and Wild, C. (2009): Classification of disease severity for neuro- and trauma rehabilitation Part 1: instruments for stroke and traumatic brain injury . HTA-Projektbericht 023a.

Wild, C. (2004): [Intraoperative radiotherapy in early stage breast cancer]. HTA-Newsletter 24: p. 4.

Wild, C. (2004): [HTAi annual meeting in Krakow]. ITA-Newsletter September 2004: pp. 11-13.

Wild, C. (2006): [Critical scientific methods for evaluating the effects of medical interventions]. Der Anaesthesist 55 (05): pp. 568-577.

Wild, C. (2005): [Needs assessment in medical care: ICU beds]. In: Nentwich, M. and Peissl, W. Technikfolgenabschätzung in der österreichischen Praxis: Wien: Verlag der ÖAW, 179 -198. ISBN 978-3-7001-3613-2.

Wild, C. (2002): [Infliximab for Crohn's disease]. HTA-Newsletter 11: p. 4.

Wild, C. (2005): [Maintaining a health care system based on solidarity]. Solidarity between generations: Women - family - society. Judenburg, 14. Juni 2005.

Wild, C. and Narath, M. (2005): Evaluating and planning ICUs: Methods and approaches to differentiate between need and demand. Health Policy 71 (03): pp. 289-301.

Wild, C. (2006): [Technologies for the elderly - gerontechnologies]. Congress of gerontology. Vienna, 09.05.2006.

Wild, C. and Puig, S. (2004): [Me-too pharmaceuticals - Marketing-strategies of drug producers and drug purchasers. Example: Non-ionic contrast media]. Das Gesundheitswesen 66 (11): pp. 716-722.

Wild, C. (2006): [Acute care for older persons: A multi-disciplinary approach]. ÖKZ: Österreichische Krankenhauszeitung 47 (04): p. 16.

Wild, C. (2005): Health technology assessment (HTA). Graduate course in public health and hospital management. Wels, 14. Oktober 2005.

Jonas, S. and Wild, C. and Schamberger, C. (2003): [Predictive genetic testing for breast and colorectal cancer]. ZaeFQ: Zeitschrift für ärztliche Fortbildung und Qualitätssicherung 97 (01): pp. 67-71.

Wild, C. (2004): [HTAi annual meeting in Krakow]. ÖKZ: Österreichische Krankenhauszeitung 45 (7/8): pp. 34-35.

Wild, C. (2005): [Robot assisted surgery]. ÖKZ: Österreichische Krankenhauszeitung 46 (12): p. 11.

Wild, C. (2005): [The Medical Association´s policy and evidence-based medicine]. Qualitas 12 (04): p. 11.

Wild, C. and Jonas, S. and Schamberger, C. (2003): Predictive genetic testing for hereditary cancer. Value in Health 6 (6): pp. 794-795.

Wild, C. (2005): [Kyphoplasty registries and HTA]. HTA in hospitals. Vienna, 27.09.2005.

Wild, C. (2004): [The Austrian health care system]. CliniCum (1-2): p. 54.

Wild, C. (2007): [FDA: Safety warning on erythropoietin]. ÖKZ: Österreichische Krankenhauszeitung 48 (07).

Wild, C. (2004): [HTA´s role in the maintenance of a health care system based on solidarity]. ITA-Newsletter June 2004: p. 10.

Wild, C. (2005): [6th Annual Meeting of the German Network for Evidence Based Medicine. Workshop: Bias spotting. Editorial]. HTA-Newsletter 35: p. 1.

Adlbrecht, C. and Wild, C. (2010): Radionuclide therapy - 90Yttrium and 177Lutetium somatostatin analogues for the treatment of inoperable neuroendocrine tumors. Decision Support Document 40.

Wild, C. (2004): [Robodoc®: Robotics in surgery]. HTA-Newsletter 28: pp. 3-4.

Wild, C. (2002): [Guidance for manufacturers and medical associations on submission of evidence]. ITA-Newsletter September 2002: p. 11.

Wild, C. (2005): [Prosthetic intervertebral disc replacement]. HTA-Newsletter 33: pp. 3-4.

Wild, C. (2005): [Targeted therapies]. ITA-Newsletter September 2005: pp. 11-12.

Wild, C. (2004): [Short acting insulin analogues in the treatment of diabetes mellitus]. HTA-Newsletter 29: p. 2.

Wild, C. (2004): [Methods of hysterectomy]. HTA-Newsletter 30: p. 2.

Wild, C. (2004): [Bisphosphonates: Treatment of bone metastases]. HTA-Newsletter 27: p. 2.

Wild, C. (2004): [Prevention and therapy of Hepatitis C]. HTA-Newsletter 29: pp. 3-4.

Wild, C. (2005): [The morning-after pill: Emergency contraception]. HTA-Newsletter 38: pp. 2-3.

Wild, C. (2003): [Cryosurgery for prostate cancer]. HTA-Newsletter 23: p. 2.

Wild, C. (2004): [Directives for end-of-life care: Living will and health care power of attorney]. HTA-Newsletter 32: pp. 3-4.

Wild, C. (2001): [Extracorporeal shock wave therapy in orthopedics]. HTA-Newsletter 01: p. 4.

Wild, C. (2005): [Medical progress. Editorial]. HTA-Newsletter 40: pp. 1-2.

Wild, C. (2004): [Age-related macular degeneration: An update]. HTA-Newsletter 26: pp. 3-4.

Wild, C. (2002): [Predictive genetic testing for breast and prostate cancer]. HTA-Newsletter 07: p. 2.

Wild, C. (2004): [Telephone triage services]. HTA-Newsletter 30: pp. 3-4.

Wild, C. (2004): [LeukoScan®: Diagnostics of osteomyelitis]. HTA-Newsletter 26: pp. 2-3.

Wild, C. (2004): [The Oregon drug class review project as initiative for generics. Editorial]. HTA-Newsletter 28: p. 1.

Wild, C. (2004): [CT and MR angiography. Diagnostics of renal artery stenosis]. HTA-Newsletter 27: pp. 3-4.

Wild, C. (2003): [Mental illness and the identification of risk groups]. HTA-Newsletter 16: p. 2.

Wild, C. (2004): [ERCP vs. MRCP: Diagnostics of biliary tract diseases]. HTA-Newsletter 27: pp. 2-3.

Wild, C. (2004): [Vacuum assisted closure for treating wounds]. HTA-Newsletter 31: pp. 2-3.

Wild, C. (2003): [Viscosupplementation in the treatment of osteoarthritis]. HTA-Newsletter 19: pp. 3-4.

Wild, C. (2003): [Evaluating organisational performance: Quantitative and qualitative methods]. ITA-Newsletter March 2003: p. 9.

Wild, C. (2004): [Mammography screening in Austria. Editorial]. HTA-Newsletter 24: pp. 1-2.

Wild, C. (2003): [Hip arthroplasty]. HTA-Newsletter 22: p. 2.

Wild, C. (2002): [New anti-cancer drugs]. ITA-Newsletter December 2002: p. 9.

Wild, C. and Grössmann, N. (2019): FoundationOne®CDx: genetic profiling of solid tumours. Rapid Assessment 014.

Wild, C. (2004): [Photodynamic therapy/PDT]. HTA-Newsletter 27: p. 4.

Wild, C. (2005): [Statement of the Viennese Bioethics Commission on advance directives. Editorial]. HTA-Newsletter 41: p. 1.

Wild, C. (2005): [Obituary: Dr. Susanna Jonas. Editorial]. HTA-Newsletter 38: p. 1.

Wild, C. (2004): [Endometrial ablation techniques in the treatment of uterine bleeding]. HTA-Newsletter 32: p. 2.

Zechmeister, I. and Wild, C. (2006): [Statins and their prognosed as well as real impact on hospital services in Austria]. ITA-Projektbericht 30.

Wild, C. and Hintringer, K. and Narath, M. (2013): Hadron therapy: Proton and carbon ion therapy - A review of clinical evidence of efficacy, ongoing research and reimbursement. HTA-Projektbericht 74.

Wild, C. and Groth, S. (2003): . ITA-Newsletter March 2003: p. 8.

Wild, C. (2004): [Home-based chemotherapy: Evaluation criteria]. HTA-Newsletter 30: p. 4.

Wild, C. (2003): [Ambulatory versus stationary haemodialysis for people with end-stage renal failure]. HTA-Newsletter 20: p. 4.

Wild, C. (2003): [HTA in hospitals]. ITA-Newsletter September 2003: pp. 9-10.

Wild, C. (2003): [Graftskin (Apligraf®) in the treatment of venous leg ulcers]. HTA-Newsletter 21: pp. 3-4.

Peissl, W. and Tellioglu, H. and Wild, C. and Nentwich, M. (1997): [The digital hospital / PACS]. ITA-Projektbericht 9.

Wild, C. (2003): [Foundation of the Austrian network "HTA in hospitals". Editorial]. HTA-Newsletter 15: p. 1.

Wild, C. (2001): [Brachytherapy for prostate cancer]. HTA-Newsletter 02: p. 3.

Wild, C. (2003): [The digestive endoscopic imaging capsule]. HTA-Newsletter 20: pp. 2-3.

Wild, C. (2002): [Robotic surgery]. HTA-Newsletter 08: p. 2.

Wild, C. (2003): [Patient information in screening programmes. Editorial]. HTA-Newsletter 18: pp. 1-2.

Wild, C. (2003): [Decision making in health care. Editorial]. HTA-Newsletter 17: p. 1.

Wild, C. (2004): [Teriparatide (Forsteo®) in the treatment of osteoporosis]. HTA-Newsletter 28: p. 4.

Wild, C. (2003): [Interventions for preventing obesity in children and adolescents]. HTA-Newsletter 16: pp. 2-3.

Wild, C. (2002): [Rationing in health care]. ITA-Newsletter December 2002: p. 8.

Wild, C. and Hahn, R. (2000): [Near-patient CRP testing by physicians in private practice to reduce antibiotic prescriptions]. ITA-Projektbericht 16.

Wild, C. (2004): [Stereotactic radiosurgery]. HTA-Newsletter 25: p. 4.

Wild, C. (2004): [Implantable defibrillators/ICD]. HTA-Newsletter 31: p. 2.

Wild, C. (2003): [Newborn hearing screening]. HTA-Newsletter 14: pp. 2-3.

Wild, C. (2003): [Recombinant human growth hormone (GH) therapy]. HTA-Newsletter 21: p. 2.

Wild, C. (2002): [ISTAHC 2002: Trends and tendencies]. ITA-Newsletter September 2002: p. 10.

Wild, C. (2003): [Extracorporeal immunoadsorption treatment]. HTA-Newsletter 19: pp. 2-3.

Wild, C. (2003): [Endoscopic sinus surgery for nasal polyps]. HTA-Newsletter 22: pp. 3-4.

Wild, C. (2003): [Use of genotypic resistance testing to optimise HIV-therapy]. HTA-Newsletter 14: p. 3.

Wild, C. (2004): [Whole-body computed tomography as a screening test]. HTA-Newsletter 29: pp. 2-3.

Wild, C. (2004): [Shared decision making. Editorial]. HTA-Newsletter 26: p. 1.

Wild, C. (2005): [Financing of health care: Liberalisation and sociopolitical implications. Editorial]. HTA-Newsletter 37: p. 1.

Wild, C. (2003): [Tumour vaccination]. HTA-Newsletter 19: p. 4.

Wild, C. (2003): [MARS® liver support]. HTA-Newsletter 20: p. 2.

Wild, C. (2001): [Tension free vaginal tape (TVT) for urinary incontinence of women]. HTA-Newsletter 02: pp. 2-3.

Patera, N. and Wild, C. (2014): Assessment – APPRAISAL – Decision: (Good) Practice examples and recommendations. Decision Support Document 72.

Wild, C. (2003): [High-dose chemotherapy]. HTA-Newsletter 22: p. 4.

Wild, C. (2003): [Digital mammography/DM]. HTA-Newsletter 15: pp. 2-3.

Wild, C. (2002): [Rationing in health care. Editorial]. HTA-Newsletter 11: pp. 1-2.

Wild, C. (2003): [Electromagnetic field therapy]. HTA-Newsletter 14: p. 2.

Wild, C. (2002): [Psoriasis]. HTA-Newsletter 09: p. 3.

Johansson, T. and Wild, C. (2009): Telemedicine in Stroke Management. Systematic Review. HTA-Projektbericht 029.

Wild, C. (2003): [Health promotion in companies and schools]. HTA-Newsletter 16: p. 4.

Wild, C. (2002): [Tandem mass spectometry (TMS) and neonatal screening]. HTA-Newsletter 10: pp. 3-4.

Wild, C. (2003): [Activated protein C for severe sepsis]. HTA-Newsletter 18: p. 2.

Wild, C. and Langer, T. (2008): EU-wide newsletter on emerging technologies: Informing and supporting health policy early . Health Policy 2008. (In Press)

Wild, C. (2005): [Case series studies]. HTA-Newsletter 35: p. 2.

Wild, C. (2003): [Liquid-based cytology in cervical screening]. HTA-Newsletter 19: p. 2.

Wild, C. (2003): [Lifestyle and physical activity]. HTA-Newsletter 16: pp. 3-4.

Wild, C. (2001): [Treatment of autism]. HTA-Newsletter 01: pp. 3-4.

Wild, C. (2003): [Medical one-way devices]. HTA-Newsletter 15: p. 3.

Wild, C. (2002): [Antifungal agents in the treatment of invasive aspergillosis]. HTA-Newsletter 04: p. 4.

Wild, C. (2001): [Autologous chondrocyte transplantation (ACI) in treating cartilage damage]. HTA-Newsletter 02: p. 2.

Wild, C. (2002): [In vitro fertilisation and intracytoplastic sperm injection]. HTA-Newsletter 06: pp. 2-3.

Wild, C. (2002): [The KoA-committee in Germany. Editorial}. HTA-Newsletter 10: pp. 1-2.

Wild, C. (2001): [European Collaboration in HTA]. HTA-Newsletter 01: p. 4.

Wild, C. and Kirschner, A., eds. (1994): Technologies for the elderly/gerontechnology: Experiences with safety alarm systems, housing adaptation with technical aids and smart homes in European countries. Netherlands: Akontes Publication.

Wild, C. (2003): [Autologous chondrocyte transplantation of the knee]. HTA-Newsletter 20: pp. 3-4.

Wild, C. (2007): [Drug Eluting Stents (DES). Update February 27th, 2007. HTA in hospitals]. HTA in hospitals. Vienna, 27.02.2007.

Wild, C. (2003): [Tools for decision-making. Editorial]. HTA-Newsletter 21: p. 1.

Wild, C. (2002): [Ultrasound screening for hip dysplasia in newborns]. HTA-Newsletter 12: pp. 2-3.

Wild, C. (2002): [Evidence-based dentistry]. HTA-Newsletter 09: p. 2.

Wild, C. (2002): [Tinnitus retraining therapy]. HTA-Newsletter 11: pp. 2-3.

Wild, C. (2003): [Organisational performance and its appraisal. Editorial]. HTA-Newsletter 14: p. 1.

Jonas, S. and Jessner, W. and Rafetseder, O. and Wild, C. (2004): [Chronic hepatitis C: Implications for therapy and economic resources in Austria]. ITA-Projektbericht 26.

Wild, C. (2003): [Computed tomography in screening for lung cancer]. HTA-Newsletter 21: p. 4.

Wild, C. (2006): [EUnetHTA - 2006-2008]. ITA-Newsletter March 2006: p. 7.

Mad, P. and Johansson, T. and Guba, B. and Wild, C. (2008): Clinical Pathways: Systematic Review of outcome parameters and effectiveness. HTA-Projektbericht 16.

Wild, C. (2002): [The EndoCinch suturing system]. HTA-Newsletter 06: pp. 3-4.

Wild, C. (2003): [Diagnosis of osteoporosis]. HTA-Newsletter 15: p. 2.

Wild, C. (2003): [Psychotherapy]. HTA-Newsletter 23: p. 4.

Wild, C. (2005): [Insulin pump. Intensive therapy for type 1 diabetes]. HTA-Newsletter 36: p. 4.

Wild, C. (2001): [Age related macular degeneration. Photodynamic therapy]. HTA-Newsletter 01: p. 3.

Wild, C. (2001): [Botulinim toxin and other spasmolytics for treatment of spasticity]. HTA-Newsletter 03: p. 3.

Wild, C. (2002): [Glitazone in the treatment of type 2 diabetes mellitus]. HTA-Newsletter 05: p. 2.

Wild, C. (2001): [Drug treatments for Alzheimer's disease]. HTA-Newsletter 03: pp. 3-4.

Blagojevic, S. and Hinterreiter, G. and Wild, C. (2011): Annual Report 2010. English version.

Fried, A. and Wild, C. (2016): Involvement of Citizens and Patients in HTA-Processes – International Experiences and Good Practice Examples. HTA-Projektbericht 86.

Wild, C. (2001): [Hyperbaric oxygen]. HTA-Newsletter 03: p. 2.

Wild, C. (2002): [Diabetic foot syndrome: Early diagnosis and treatment costs]. HTA-Newsletter 05: pp. 3-4.

Wild, C. (2002): [COX-2 inhibitors in the treament of arthritis]. HTA-Newsletter 06: p. 4.

Wild, C. (2002): [Intensive care units: An evidence-based needs assessment for Austria]. HTA-Newsletter 10: p. 2.

Rummel, P. and Hawlik, K. and Wild, C. (2016): Health Technology Assessments on Medical Devices in Europe. Rapid Assessment 012.

Wild, C. (2001): [Health Technology Assessment and decision making. Editorial]. HTA-Newsletter 00: pp. 1-2.

Wild, C. (2002): [Is critical journalism contradictory to the reporting of innovations? Editorial]. HTA-Newsletter 04: p. 1.

Mathis, S. and Wild, C. and Piso, B. and Piribauer, F. (2009): Evidence supported health services planning. HTA Projektbericht 021.

Wild, C. (2002): [Vaccines for preventing influenza]. HTA-Newsletter 07: pp. 3-4.

Wild, C. and Adlbrecht, C. (2007): [Radiopharmaceuticals in palliative care]. HTA-Newsletter 58: pp. 2-3.

Wild, C. (2001): [Sacral neuromodulation in the treatment of urinary incontinence]. HTA-Newsletter 03: pp. 2-3.

Wild, C. (2002): [Ritalin for attention deficit hyperactivity disorder/ADHD]. HTA-Newsletter 07: pp. 2-3.

Wild, C. (2002): [Surgical treatment of obesity]. HTA-Newsletter 08: p. 4.

Radlberger, P. and Johansson, T. and Wild, C. (2009): Economic aspects of clinically effective and efficient models of health services in alcohol addiction treatment Part 1: International models and approaches of outcome measurement Part 2: Selected models of integrated care and their evaluation. HTA-Projektbericht 010.

Wild, C. (2002): [Tacrolimus ointment for the treatment of atopic dermatitis/AD]. HTA-Newsletter 10: pp. 2-3.

Wild, C. (2005): [Sonography of the acute abdomen]. HTA-Newsletter 37: pp. 3-4.

Wild, C. (2002): [Pallidotomy in Parkinson's disease]. HTA-Newsletter 07: p. 4.

Wild, C. (2002): [New drugs in the treatment of cancer. Editorial]. HTA-Newsletter 12: p. 1.

Wild, C. (2004): [Non-ionic contrast media]. HTA-Newsletter 25: p. 2.

Wild, C. (2003): [Anaesthetics in day surgery]. HTA-Newsletter 17: p. 4.

Wild, C. (2002): [Youth suicide prevention]. HTA-Newsletter 09: p. 4.

Adlbrecht, C. and Wild, C. (2007): [Targeted radionuclide therapy with 90Y- and 177-Lu-DOTATOC in patients with neuroendocrine tumors. HTA in hospitals]. Decision Support Document 02.

Wild, C. (2001): [Cytomegalovirus prophylaxis and therapy]. HTA-Newsletter 02: pp. 3-4.

Wild, C. and Khan, A. and Erdos, J. (2015): Sponsoring of Patient Initiatives in Austria. Systematic Analysis. Rapid Assessment 007b.

Mantsch, S. and Petersen, P. and Wild, C. (2016): Pharma: Disclosure of payments in Austria 2015. Rapid Assessment 007d.

Wild, C. (2001): [IOM report "To Err is Human"]. ITA-Newsletter March 2001: pp. 8-9.

Wild, C. (2002): [ISTAHC 2002: Trends and tendencies. Editorial]. HTA-Newsletter 09: p. 1.

Wild, C. (2007): [Biosimilars]. HTA-Newsletter 54: p. 2.

Wild, C. (2002): [Insulin analogues]. HTA-Newsletter 05: p. 3.

Wild, C. (2002): [Laser-induced thermotherapy (LITT) in the treatment of malignant tumours]. HTA-Newsletter 06: p. 2.

Wild, C. (2003): [Racz-catheter for chronic back pain]. HTA-Newsletter 17: p. 2.

Wild, C. (2002): [Stapled haemorrhoidectomy]. HTA-Newsletter 10: p. 4.

Mad, P. and Wild, C. (2007): [Photodynamic therapy for the treatment of malignant stenosis in the alimentary tract. HTA in hospitals]. Decision Support Document 03.

Wild, C. and Blagojevic, S. (2020): Jahresbericht 2019.

Wild, C. and Blagojevic, S. (2014): Annual Report 2013.

Wild, C. and Khene, M. and Wanke, S. (1998): [Extracorporeal shock wave therapy (ESWT). Final report]. ITA-Projektbericht 10.

Blagojevic, S. and Wild, C. (2012): Annual Report 2011. English Version.

Wild, C. (2002): [Bupropion in smoking cessation]. HTA-Newsletter 09: pp. 2-3.

Wild, C. (2002): [Living donor transplantation]. HTA-Newsletter 11: pp. 3-4.

Wild, C. (2002): [Alpha lipoic acid in the treatment of neuropathy]. HTA-Newsletter 05: pp. 2-3.

Wild, C. (2004): [Sclerotherapy for leg varicose veins]. HTA-Newsletter 30: pp. 2-3.

Wild, C. (2010): Percutaneous aortic valve replacement. Decision Support Document 18/Update 2010.

Schiller-Frühwirth, I. and Wild, C. and Geiger-Gritsch, S. and Mittermayr, T. (2009): Intraoperative radiotherapy for primary breast cancer. Systematic Review.. Decision Support Document 23.

Wild, C. (2005): [Recombinant activated C protein for severe sepsis]. HTA-Newsletter 38: p. 4.

Wild, C. (2003): [Clinical economics]. ITA-Newsletter September 2003: pp. 10-11.

Wild, C. (2003): [Extracorporeal shock wave therapy (ESWT) for pseudarthrosis]. HTA-Newsletter 22: pp. 2-3.

Wild, C. (2006): [Rheumatoid arthritis: Targeted immune modulators]. HTA-Newsletter 46: p. 2.

Wild, C. (1998): [HTA as steering tool]. ITA-Newsletter October 1998: pp. 20-21.

Wild, C. (2005): [Glucosamine sulphate for osteoarthritis]. HTA-Newsletter 41: p. 4.

Wild, C. and Narath, M. and Frank, W. (2002): [Evidence-based ICU bed planning]. ITA-Projektbericht 23.

Fried, A. and Wild, C. (2013): Hybrid operating room. Rapid Assessment 006.

Wild, C. (2005): [Neuromodulation in patients with Parkinson´s disease or chronic pain]. HTA-Newsletter 37: p. 2.

Wild, C. (2005): [Computer-aided detection (CAD) in mammography]. HTA-Newsletter 37: pp. 2-3.

Wild, C. (2005): [Chemonucleolysis for herniated disc]. HTA-Newsletter 42: pp. 2-3.

Wild, C. (2006): [Diagnostics of urinary incontinence]. HTA-Newsletter 46: pp. 2-3.

Wild, C. (2005): [Genotyping for cytochrome P450 polymorphisms]. HTA-Newsletter 33: pp. 2-3.

Wild, C. (2005): [Trigger point injections (TPI) for non-malignant musculoskeletal pain]. HTA-Newsletter 34: pp. 2-3.

Wild, C. (1998): [Delphi-Austria: foresight on medical technologies and social-organisational developments in health care]. Delphi Report Austria 2.

Wild, C. (2006): [Infliximab for Crohn’s disease]. HTA-Newsletter 45: p. 2.

Wild, C. (2005): [Avastin®/Bevacizumab for metastatic colorectal cancer]. HTA-Newsletter 40: p. 2.

Wild, C. and Blagojevic, S. (2015): Annual Report 2014.

Wild, C. (2006): [Interferon-beta for multiple sklerosis]. HTA-Newsletter 45: pp. 2-3.

Wild, C. (2004): [New technologies in cervical cancer screening]. HTA-Newsletter 29: p. 4.

Eder, C. and Wild, C. (2019): Advanced Therapy Medicinal Products (ATMPs): Technology forecast. Journal of Market Access & Health Policy 7 (1).

Gottardi, R. and Wild, C. (2011): Percutaneous aortic valve replacement (with a side note on hybrid operating rooms). Decision Support Document 18/Update 2011.

Wild, C. (2006): [Tube feeding in the demented elderly]. HTA-Newsletter 44: p. 4.

Korencan, A. and Guba, B. and Wild, C. (2007): Testing for HER2 positive breast cancer. Challenge for improvement of current conditions and practice. HTA-Projektbericht 08.

Jonas, S. and Rafetseder, O. and Wild, C. (2003): [Colorectal cancer screening in Austria: Integrating coloscopy/sigmoidoscopy into the preventive medical check up. An unsystematic review]. ITA-Projektbericht 25.

Wild, C. (2004): [Genetic testing for predisposition]. HTA-Newsletter 31: p. 4.

Piso, B. and Wild, C. and Winkler, R. and Warmuth, M. (2011): Reorientation of the Austrian parent-child preventive care programme. Part IV: Synthesis of parts I-III, recommendations. HTA-Projektbericht 045d.

Wild, C. (2002): [Positron emission tomography/PET]. HTA-Newsletter 08: pp. 2-3.

Wild, C. (2005): [Immunoglobulin in neonates and preterm infants]. HTA-Newsletter 41: pp. 2-3.

Wild, C. (2002): [Meeting the needs of intensive care]. ITA-Newsletter September 2002: p. 5.

Wild, C. (2006): [Pegaptanib (Macugen®) for age-related macular degeneration (AMD)]. HTA-Newsletter 46: pp. 3-4.

Wild, C. (2004): [The myth of cancer prevention: Heresy or guidance to maturity. Editorial]. HTA-Newsletter 27: p. 1.

Abuzahra, M. and Zechmeister, I. and Wild, C. (2009): International comparison of antenatal care in pregnant women. Decision Support Document 33.

Wild, C. (2004): [Breast cancer diagnosis by magnetic resonance imaging or positron emission tomography (PET)]. HTA-Newsletter 24: pp. 3-4.

Wild, C. (2005): [Treatment of dental caries: Ozone therapy]. HTA-Newsletter 43: pp. 2-3.

Wild, C. (2005): [Foundation of an Austrian HTA institute]. ITA-Newsletter March 2005: p. 2.

Vreugdenburg, Thomas and Wild, C. (2017): Prostate artery embolisation for benign prostatic hyperplasia. Decision Support Document 105.

Wild, C. (2001): [Erythropoietin for anaemic tumour patients]. HTA-Newsletter 01: p. 2.

Mathis-Edenhofer, S. and Schramm, F. and Wild, C. (2012): Re-orientation of the Austrian parent-child preventive health care programme, Part VII: The potential of an electronic implementation. HTA- Projektbericht 54 .

Wild, C. (2005): [Cognitive training in senile dementia]. HTA-Newsletter 43: p. 4.

Wild, C. (2006): [Diagnosis of the menopause: FSH and LH levels]. HTA-Newsletter 44: p. 2.

Hintringer, K. and Wild, C. (2009): Bioresonance for allergiges, atopic dermatitis, non-organic gastrointestinal complaints, pain and rheumatic diseases. Decision Support Document 31.

Wild, C. (2005): [Statins for acute coronary syndrome]. HTA-Newsletter 42: pp. 3-4.

Wild, C. (2005): [Surgery for morbid obesity]. HTA-Newsletter 42: p. 2.

Wild, C. (2006): [Artificial nutrition in geriatric care]. HTA-Newsletter 49: pp. 3-4.

Wild, C. (2006): [EUnetHTA 2006-2008. Editorial]. HTA-Newsletter 44: p. 1.

Wild, C. (2006): [Acute care for the elderly: Models of multidisciplinary health care]. HTA-Newsletter 44: pp. 3-4.

Wild, C. (2005): [Erbitux®/Cetuximab for metastatic colorectal cancer]. HTA-Newsletter 40: pp. 2-3.

Wild, C. (2001): [HTA newsletter]. ITA-Newsletter December 2001: p. 11.

Wild, C. (2005): [Medical progress. Editorial]. HTA-Newsletter 40: pp. 1-2.

Wild, C. (2005): [Methods for meta-analyses of diagnostic accuracy studies]. HTA-Newsletter 35: pp. 2-3.

Wild, C. (2005): [Randomised versus non-randomised studies] . HTA-Newsletter 35: p. 4.

Radlberger, P. and Wild, C. and Guba, B. (2007): [Mammography screening. Evidence-based evaluation of mammography-based breast cancer screening programmes]. HTA-Projektbericht 07.

Wild, C. (2005): [Measuring patient-based outcomes]. HTA-Newsletter 35: pp. 3-4.

Mad, P. and Geiger-Gritsch, S. and Mittermayr, T. and Wild, C. (2009): Tocolysis in preterm labour - A systematic review of evidence-based guidelines, effectiveness and health economic evaluations. HTA-Projektbericht 030.

Wild, C. (2005): [Treatment of osteoporosis]. HTA-Newsletter 41: pp. 3-4.

Grössmann, N. and Wild, C. and Nachtnebel, A. (2015): Horizon Scanning in Oncology: Results of the 25th Prioritisation – 4th quarter 2015. HSO: 25th Prioritisation.

Wild, C. (2001): [Project on generics: Saving 5 million schilling]. ITA-Newsletter December 2001: p. 10.

Wild, C. and Jonas, S. (2000): [HTA-workshop of European social insurance agencies]. ITA-Newsletter December 2000: p. 8.

Wild, C. (2004): [Screening for colorectal cancer in Austria]. HTA-Newsletter 25: pp. 2-3.

Künzl, M. and Wild, C. and Mathis, S. and Johansson, T. (2009): Autologous Chondrocyte Implantation. Systematic Review. Decision Support Document 34.

Wild, C. (2004): [Breast cancer care: Quality indicators]. HTA-Newsletter 32: p. 4.

Wild, C. (2002): [Screening for colorectal cancer]. HTA-Newsletter 04: p. 4.

Wild, C. (2003): [HTA and the commercialisation of new technologies. Editorial]. HTA-Newsletter 20: p. 1.

Wild, C. (2005): [Hyperthermia in the treatment of malignant tumours]. HTA-Newsletter 34: p. 2.

Wild, C. and Jonas, S. (2001): [Immunoglobulins in transplant medicine: Prevention and therapy of cytomegalovirus infections]. ITA-Newsletter September 2001: pp. 9-10.

Wild, C. (2005): [Intraoperative ablation for atrial fibrillation]. HTA-Newsletter 33: p. 2.

Wild, C. (2001): [Stem cell research, quo vadis? Editorial]. HTA-Newsletter 03: pp. 1-2.

Wolf, S. and Wild, C. (2018): Drug reimbursement in the inpatient sector in Austria: Approaches for a transparent and evidence-based process, taking into account international experience . HTA-Projektbericht 109.

Wild, C. and Blagojevic, S. and Sehic, O. (2019): Jahresbericht 2018.

Wild, C. (2004): [Transparency in the pharmaceutical industry. Editorial]. HTA-Newsletter 25: pp. 1-2.

Wild, C. (2005): [Auditory brain stem implants]. HTA-Newsletter 34: p. 3.

Wild, C. (2001): [International symposium on health technology assessment]. ITA-Newsletter March 2001: p. 9.

Zechmeister, I. and Wild, C. and Langer, T. and Koller, D. (2007): [Neonatal care of low-risk newborns. An approach to evidence-based health care planning in Styria] . HTA-Projektbericht 04.

Wild, C. (2015): Hadron therapy in children: evidence synthesis for 15 paediatric tumours. Report based on Belgian (KCE) HTA report. Decision Support Document 88.

Wild, C. (2001): [European HTA project comes to an end in September]. ITA-Newsletter September 2001: pp. 10-11.

Wild, C. (2001): [Generics and cost reduction: A project in Austria]. HTA-Newsletter 02: p. 4.

Abraha, I. and Chiarolla, E. and Corio, M. and Gillespie, F. and Migliore, A. and Cerbo, M. and Lauvrak, V. and Fagerlund, B.C. and Harboe, I. and Stoinska-Schneider, A. and Wild, C. (2019): Transcatheter aortic valve implantation (TAVI) in patients at intermediate surgical risk. HTA-Projektbericht 115.

Wild, C. (2000): [HTA and decision making]. ITA-Newsletter April 2000: p. 6.

Wild, C. and Küllinger, R. and Hintringer, K. (2015): The sponsoring of Austrian CME/continuing medical education for physicians. A systematic analysis of the CME-Database. Rapid Assessment 007a.

Wild, C. and Patera, N. and Küllinger, R. and Narath, M. (2015): PET/PET-CT Evidence for need based planning (in oncology indications). HTA-Projektbericht 77.

Busse, R. and Orvain, J. and Drummond, M. and Wild, C. (2001): Best practice in undertaking and reporting HTA. Working Group 4 Final Report. Projektbericht.

Hintringer, K. and Wild, C. (2009): Colon Hydrotherapy for defecation disorders. Systematic Review. Decision Support Document 32.

Falkner, E. and Wild, C. (2007): Cell salvage for minimising perioperative allogeneic blood transfers]. HTA-Newsletter 59: p. 3.

Wild, C. (2015): Transcatheter implantable devices for mitral valve repair in adults with chronic mitral valve regurgitation (MitraClip®, Carillon®, NeoChord DS1000). German short version of the correspondent EUnetHTA assessment. Decision Support Document 93.

Wild, C. (2020): Update 12 months follow-up: Nusinersen in spinal muscular atrophy ("late onset") in children and adolescents ≥ 6 years. AIHTA Policy Brief 001.

Wild, C. and Blagojevic, S. (2016): Annual Report 2015.

Wild, C. (2004): [Electrostimulation after stroke]. HTA-Newsletter 25: pp. 3-4.

Wild, C. (2005): [Proton therapy]. HTA-Newsletter 43: p. 3.

Wild, C. (2001): [Innovations and (expensive) followers. Editorial]. HTA-Newsletter 02: pp. 1-2.

Piso, B. and Wild, C. (2008): Rational Vaccination Policies - decision support. Review of International Literature for "Rational" Vaccination Policies. Rapid Assessment LBI-HTA 03.

Wild, C. (2000): [ISTHAC 2002 in Berlin]. ITA-Newsletter September 2000: p. 8.

Patera, N. and Wild, C. (2009): Status quo mammography screening: evaluation results from organised programs. HTA-Projektbericht 035.

Wild, C. (2000): [EPO for cancer related anaemia]. ITA-Newsletter April 2000: p. 5.

Mathis, S. and Wild, C. (2008): [Clinical and health economic registries in the field of cardiovascular, spinal and neurologic diseases. Methods and good practice strategies]. HTA-Projektbericht 11.

Wild, C. (2001): [Innovations and (expensive) followers]. ITA-Newsletter December 2001: p. 9.

Wild, C. and Goldgruber, R. (2004): [Non-commercial clinical trials]. ITA-Newsletter March 2004: pp. 10-11.

Wild, C. (2003): [HTA and the commercialisation of new technologies] . ITA-Newsletter December 2003: pp. 10-11.

Wild, C. and Patera, N. (2014): Stereotactic Radiofrequency ablation/ SRFA for hepatocellular carcinoma and liver metastases. Decision Support Document 76.

Wild, C. (2004): [Epithelial cell cytology in breast cancer risk assessment]. HTA-Newsletter 24: p. 2.

Wild, C. and Jonas, S. (2000): [EPO in cancer anaemia]. ITA-Newsletter September 2000: pp. 2-3.

Warmuth, M. and Mad, P. and Piso, B. and Schumacher, I. and Wild, C. (2011): Reorientation of the Austrian parent-child preventive care programme. Part I: Epidemiology - Frequency of risk factors and disease during pregnancy and early childhood. HTA-Projektbericht 045a.

Wild, C. (2002): [Critical journalism: Evidence-based reporting of innovations]. ITA-Newsletter March 2002: p. 8.

Patera, N. and Wild, C. (2012): Generic indicators for process quality in oncological care: A compendium. HTA-Projektbericht 49b.

Wild, C. (2002): [Guidelines for manufacturers and medical associations on submission of evidence. Editorial]. HTA-Newsletter 08: p. 1.

Wild, C. (2001): [Limits of the evidence-based medicine: Conflicts of interests]. ITA-Newsletter December 2001: p. 10.

Petersen, P. and Wild, C. (2017): Sponsoring of Patientinitiatives in Austria 2015. Update of the Systematic Analysis 2014.. Rapid Assessment 007b_1. Update 2017.

Wild, C. (2004): [The Oregon drug class review project as initiative for generics]. ITA-Newsletter September 2004: p. 13.

Wild, C. (2003): [Guidance for manufacturers and medical associations on submission of evidence]. ITA-Newsletter December 2003: p. 9.

Schmidt, L. and Prenner, A. and Lohr, P. and Wild, C. (2019): Public & philanthropic financial contribution to the development of new drugs: Methodology & 3 Case Studies. HTA-Projektbericht 120.

Schiller-Frühwirth, I. and Wild, C. (2012): Intraoperative radiotherapy for primary breast cancer. Decision Support Document 23 / Update 2012.

Falkner, E. and Wild, C. (2008): Clinical application of Tissue Engineering: An overview of International and Austrian Areas of Research with a critical analysis of selected applications . LBI-HTA Projektbericht 013.

Chiarolla, E. and Orso, M. and Götz, G. and Stanak, M. and Wild, C. and Jefferson, T. (2019): Wearable cardioverter-defibrillator (WCD) therapy in primary and secondary prevention of sudden cardiac arrest in patients at risk. Update 2018. Decision Support Document 103/ Update 2018.

Wild, C. (2012): Cell therapy for urinary stress incontinence. Decision Support Document 06 / Update 2012.

Wild, C. and Antes, G. (2004): [Registration of all clinical trials. Editorial]. HTA-Newsletter 30: pp. 1-2.

Grössmann, N. and Wolf, S. and Wild, C. (2016): Horizon Scanning in Oncology: Results of the 29th Prioritisation – 4th quarter 2016.. HSO: 29th Prioritisation.

Mad, P. and Langer, T. and Guba, B. and Kvas, E. and Reichelt, C. and Adlbrecht, C. and Wild, C. (2007): [Role and positioning of university outpatient departments]. HTA-Projektbericht 05.

Gregor-Patera, N. and Petersen, P. and Wild, C. (2017): Sponsoring of Patient Initiatives in Austria 2016. Update of the Systematic Analyses 2015 and 2014. Rapid Assessment 007b_2. Update 2017.

Gregor-Patera, N. and Wild, C. (2017): Research interests of Non-interventional studies (NIS) in Austria. Update of the systematic analysis. Rapid Rapid Assessment 007c. Update 2017.

Wild, C. (2007): [External manual. Part 1]. HTA-Projektbericht 03.

Grössmann, N. and Wild, C. (2016): Horizon Scanning in Oncology: Results of the 27th Prioritisation – 2nd quarter 2016 . HSO: 27th Prioritisation.

Wild, C. and Emprechtinger, R. (2016): Endovascular therapy using mechanical thrombectomy devices for acute ischaemic stroke. National Report: German Summary of the correspondent EUnetHTA Report. Decision Support Document 94.

Grössmann, N. and Wild, C. (2016): Horizon Scanning in Oncology: Results of the 28th Prioritisation – 3rd quarter 2016. HSO: 28th Prioritisation.

Fuchs, S. and Grössmann, N. and Eckhardt, H. and Busse, R. and Wild, C. (2018): PET/PET-CT Evidence for need based planning in Germany and Austria. HTA-Projektbericht 77/ Update 2018.

Wild, C. (1998): [European collaboration in health technology assessment (ECHTA)]. ITA-Newsletter October 1998: pp. 20-21.

Grössmann, N. and Wild, C. and Mayer, J. (2016): Drugs in Oncology: an overview of benefit and refund practices in Europe. Rapid Assessment 008.

Grössmann, N. and Wild, C. (2016): Horizon Scanning in Oncology: Results of the 26th Prioritisation – 1st quarter 2016. HSO: 26th Prioritisation.

Hawlik, K. and Wild, C. (2017): Extracorporeal cytokine haemadsorption in patients with sepsis or SIRS. Decision Support Document 106.

Gregor-Patera, N. and Schader , M. and Wild, C. (2016): Non-interventional studies (NIS) in Austria. A systematic analysis. Rapid Assessment 007c.

Wild, C. and Blagojevic, S. and Petersen, P. (2017): Annual Report 2016.

Wild, C. and Blagojevic, S. and Petersen, P. (2018): Annual Report 2017.

Ettinger, S. and Stanak, M. and Huić, M. and Hacek, R.T. and Ercevic, D. and Grenkovic, R. and Wild, C. (2016): Wearable cardioverter-defibrillator (WCD) therapy in primary and secondary prevention of sudden cardiac arrest in patients at risk.. Decision Support Document 103.

Emprechtinger, R. and Fischer, S. and Wild, C. (2016): Options to identify inappropriate use of MRI, Part 3. HTA-Projektbericht 80c.

Schmidt, L. and Lohr, P. and Wild, C. (2018): Stereotactic radiotherapy, proton therapy and irreversible electroporation for the treatment of localised prostate cancer. HTA-Projektbericht 107.

Wild, C. (2018): Endobronchial valve implantation for emphysema. Update 2018. Decision Support Document 20/ Update 2018.